Entity > Corporation > US > Bryan Texas > Ibio

About iBio

iBio, Inc. is a biotechnology company that provides contract development and manufacturing services to collaborators and third-party customers in the United States. It is a developer of next-generation biopharmaceuticals and the pioneer of the sustainable FastPharming Manufacturing System ®. The company operates in two segments: Biopharmaceuticals and Bioprocessing.

iBio’s High-Quality Protein Products: Current products include growth factors, cytokines and lectins, as they play an important role in the research and development of various diseases such as cancer and autoimmune diseases. iBio's high-quality proteins can be used for a variety of applications, including SDS-PAGE, ELISA, cell culture supplementation and Western blot. These products are recombinant GNA, recombinant human Flt3L with His tag (Flt3L-His), recombinant human interleukin 6 (IL -6) and recombinant human stem cell factor with His tag (SCF -His).

Pioneering the Next Generation of Biopharmaceuticals using the FastPharming Technology: The FastPharming System is iBio's proprietary approach to producing drugs and proteins in plants. It uses hydroponically grown transiently transfected plants, novel expression vectors, a large-scale transient transfection method and other technologies that can be used to produce complex therapeutic proteins. iBio believes that the FastPharming System will enable biologics production that is faster, less expensive and more environmentally friendly than other approaches.

Operating in Biopharmaceuticals and Bioprocessing Segments: iBio's biopharmaceutical segment is currently focused on developing products using the FastPharming System in the areas of therapeutics (antifibrotics and oncology) and vaccines (COVID -19 and classical swine fever). The Bioprocessing segment, on the other hand, is active in the business areas of services and research and bioprocessing.

Partnerships and Collaboration: iBio, Inc. has a licence agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases, a collaboration agreement with The Texas A&M University System to develop 2019 coronavirus disease vaccine candidates, a licence agreement with the University of Natural Resources and Life Sciences, Vienna, Austria, and a collaboration agreement with CC -Pharming Ltd. The company is headquartered in Bryan, Texas.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about iBio

Company Attribute Value
Address StreetAddress: 8800 Hsc Pkwy, AddressLocality: Bryan, AddressRegion: Texas, PostalCode: 77807, AddressCountry: United States
Founding Date 2008
Name iBio
Number Of Employees 105
Revenue $2,383,000 USD
Ticker Symbol NYSE: IBIO
Url ibioinc
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google



Bryan, US
20 May 2024

Bryan, US
20 May 2024


Page: 1 Desktop | Laptop Devices

iBio – Next Generation Antibody Therapeutics
iBio is pioneering the next generation of antibody therapeutics, leveraging our artificial intelligence-based and epitope steered antibody discovery ...
https://finance.yahoo.com › quote › IBIO
iBio, Inc. (IBIO) Stock Price, News, Quote & History
iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical ...
iBIO | To promote, connect and engage the life sciences ...
iBIO is the state trade association representing the life sciences industry in Illinois. Our membership ranges from global corporations to startup companies in ...
https://www.marketwatch.com › ... › United States
iBio Inc. Stock Quote (U.S.: NYSE American)
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It operates through the Biopharmaceuticals and ...
https://www.morningstar.com › stocks › xase › quote
IBIO Stock Price Quote
See the latest iBio Inc stock price (IBIO:XASE), related news, valuation, dividends and more to help you make your investing decisions.
https://www.nasdaq.com › Market Activity › Stocks
iBio, Inc. Common Stock (IBIO)
Discover real-time iBio, Inc. Common Stock (IBIO) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
https://www.cnn.com › markets › stocks › IBIO
IBIO Stock Quote Price and Forecast
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision ...
Related Searches
Related Searches
ibio rumors
ibio rumors reddit
ibio news
Knowledge Panel
Knowledge Panel

iBio, Inc. (Biotechnology company)


  • Stock price : IBIO (NYSEAMERICAN) $1.98 +0.17 (+9.39%)May 17, 4:00 PM EDT - Disclaimer
  • Headquarters : Newark, DE
  • Date founded : 2008

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193750